Sign in

CIK 0001422142 · Non-accelerated filer<br>Smaller reporting company

Whitehawk Therapeutics, Inc.

Sign in to watch
Ticker
WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547850
Phone
551-321-2234
Business address
2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
Former names
Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-02 Desai Neil Executive Chairman Sale −12,443 $7.99 $99K 1,814,118
2023-06-01 Desai Neil Executive Chairman Sale −4,982 $7.92 $39K 1,826,561
2023-05-04 Desai Neil Executive Chairman Sale −2,305 $7.57 $17K 1,831,543
2023-05-03 Desai Neil Executive Chairman Sale −7,695 $7.68 $59K 1,833,848
2023-05-02 Desai Neil Executive Chairman Sale −7,521 $7.48 $56K 1,841,543
2023-05-01 Desai Neil Executive Chairman Sale −24,479 $7.80 $191K 1,849,064
2023-04-06 Desai Neil Executive Chairman Sale −12,212 $7.09 $87K 1,873,543
2023-04-05 Desai Neil Executive Chairman Sale −7,336 $7.24 $53K 1,885,755
2023-04-04 Desai Neil Executive Chairman Sale −12,869 $7.30 $94K 1,893,091
2023-04-03 Desai Neil Executive Chairman Sale −9,583 $7.45 $71K 1,905,960
2023-04-03 Giacobello Scott M. CFO, Interim CEO & President Grant or award · Stock Option (right to buy) +100,000 100,000

Page 9 of 9 · 171 trades